Notwithstanding the limited number of cases with a detectable level of methylated RASSF1A, especially among healthy subjects, our results demonstrated a good capability of this marker in distinguishing between melanoma patients and healthy control subjects, as evidenced by the ROC curve analysis. This evidence concerns the gene RASSF1 and melanoma.